Aker BioMarine and Lupus Research Alliance launch a new clinical study, investigating how phospholipid-rich krill oil can benefit people with lupus, with the aim to lessen the severity of symptoms associated with the disease.
Among Black Women, Smoking Linked with Increased Lupus Risk
Lupus affects more women than men. Why? New study explores
Lupus affects nine times more women than men. Experts know that lupus erythematosus, SLE, or lupus affects many more women than men, but none of them can explain why. Now that University of Houston biomedical engineer Chandra Mohan has the funding, he has set out to determine why.
Prof. Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering, has $2 million to solve the mystery.
Corticosteroids Affect Lupus Patients’ Emotional Health, Daily Activities, Study Says
Skin’s Immune ‘Alarm’ May Explain Light-Induced Rashes in Lupus Patients
Lilly to progress Olumiant into Phase 3 for lupus
The Lancet has published full results of a Phase II trial showing the benefit of Lilly’s JAK inhibitor Olumiant in the treatment of global systemic lupus erythematosus (SLE).
According to the data, a statistically significant proportion of patients treated with 4mg of Olumiant (baricitinib) achieved resolution of their SLE-related arthritis or rash compared to placebo at week 24, thus meeting the primary endpoint of the trial.
Scientific and Technology Breakthroughs Show Promise for Lupus and Other Immunologic Diseases
The Lupus Research Alliance is pleased and very encouraged to share a promising scientific breakthrough reported in the New York Times with real potential to revolutionize lupus treatment. Just reported in the prestigious journal Nature, scientists in Dr. Alexander Marson's lab at the University of California, San Francisco have developed an innovative way to engineer genes of the body's immune system to treat immunologic diseases like lupus, rheumatoid arthritis, cancer and HIV.
Poor Sleep and Depression, via Pain, Can Affect Cognition in Lupus Patients, Study Finds
Lilly's Olumiant delivers positive Phase 2 lupus data
Obesity in Women Worsens Lupus, Increases Depression, Pain and Fatigue, Study Finds
Feinstein Institute researchers find blood markers that identify lupus risk.
New Drug Trial Aims to Help Collect Data to Treat Lupus Patients
Studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus
University of Louisville School of Medicine Researchers identify gene variants that may cause kidney problems in lupus patients
Steroids, older age worsen Lupus damage.
More sleep problems for patients with SLE
Patients with SLE had more sleep problems than the general US population, and psychosocial factors, particularly depression and anxiety, were associated with the abnormalities, according to recent study results from the University of Chicago Rheumatology clinic.
